Our upcoming January 5th meeting will be a presentation by Toni Klatt-Ellis, from Takeda Oncology, about the recently approved new oral proteasome inhibitor, Ninlaro, approved for relapsed myeloma rather than the Multiple Myeloma Overview.
Dinner provided by Takeda starting at 7 pm.
This meeting will be held at the same location except in Classroom 2 in the Women's Health Center (we are usually in classroom1)
For more information please email: email@example.com
Note: If you are feeling ill, coughing or sneezing, please do not attend the meeting! Myeloma patients are much more susceptible to getting sick because of our weakened immune systems. Cold and flu season is even riskier for us. Please be courteous to your fellow patients. Thank You!